COVID-19: our current knowledge of epidemiology, pathology, therapeutic approaches, and diagnostic methods

F Marofi, R Azizi, R Motavalli, G Vahedi… - Anti-Cancer Agents …, 2021 - ingentaconnect.com
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) firstly emerged in
Wuhan, China at the end of 2019. After going through the experimental process, the virus …

COVID-19: immunopathogenesis and Immunotherapeutics

L Yang, S Liu, J Liu, Z Zhang, X Wan… - Signal transduction and …, 2020 - nature.com
The recent novel coronavirus disease (COVID-19) outbreak, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected …

[HTML][HTML] Perspective adjunctive therapies for COVID-19: beyond antiviral therapy

P Ho, JQ Zheng, CC Wu, YC Hou, WC Liu… - … Journal of Medical …, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic is the largest health crisis
ever faced worldwide. It has resulted in great health and economic costs because no …

Treatment algorithm for COVID-19: a multidisciplinary point of view

F Galluccio, T Ergonenc, A Garcia Martos… - Clinical …, 2020 - Springer
Abstract The novel coronavirus (Sars-CoV-2) pandemic has spread rapidly, from December
to the end of March, to 185 countries, and there have been over 3,000,000 cases identified …

Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: An update

W Zhang, C Qin, Y Fei, M Shen, Y Zhou, Y Zhang… - Clinical …, 2022 - Elsevier
In March 2020, when coronavirus disease 2019 (COVID-19) was just beginning to spread
around the world, we presented the potential benefits and controversies of anti-inflammatory …

[PDF][PDF] Anti-rheumatic drugs as potential anti-inflammatory, immunomodulatory agents against COVID-19: A systematic review

R Sinaei, S Pezeshki, A Asadipour, R Shiari… - Pharmaceutical …, 2021 - ps.tbzmed.ac.ir
Background: The effective responses of both innate and adaptive immunity are crucial in
combating novel coronavirus-2 infection. An excessive response may lead to cytokine storm …

Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)

FY Chang, HC Chen, PJ Chen, MS Ho… - Journal of biomedical …, 2020 - Springer
Abstract On March 11, 2020, the World Health Organization declared the worldwide spread
of the infectious disease COVID-19, caused by a new strain of coronavirus, SARS-CoV-2, as …

[HTML][HTML] Antibody-dependent enhancement and the critical pattern of COVID-19: possibilities and considerations

F Farshadpour, R Taherkhani - Medical Principles and Practice, 2021 - karger.com
Abstract Coronavirus disease 2019 (COVID-19), a pandemic infection with profound effects
on human society, has challenged our ability to control viral infections. Although at the …

Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies

YW Zhou, Y Xie, LS Tang, D Pu, YJ Zhu… - Signal transduction and …, 2021 - nature.com
Owing to the limitations of the present efforts on drug discovery against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the lack of the understanding of the …

Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach

A Das, S Roy, S Swarnakar, N Chatterjee - Clinical Immunology, 2021 - Elsevier
Abstract In December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-
2), a novel variant of coronavirus has emerged from Wuhan in China and has created havoc …